Spot shows folks running as a symbol of how the health-challenged can chase their dreams because of Sanofi meds.

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

There is decreased risk for hospitalization in patients with heart failure who receive a high-dose inactivated influenza vaccine.

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...

The United States Adult Vaccine Market is projected to soar to US$ 11.10 billion by 2033, up from US$ 6.55 billion in 2024, ...

The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, ...

Paris, France - October 28, 2025 - Sanofi announces that it has successfully priced its offering of $3 billion of notes across 5 tranches: $400 million fixed rate notes, due November 2027, bearing ...

Sanofi India Limited (SIL) announced that its board of directors, on the recommendation of the Nomination and Remuneration ...

(Reuters) -Australian biotech CSL on Tuesday delayed its planned vaccine division spin-off and cut earnings forecasts due to a bigger-than-expected decline in U.S. flu vaccination rates, sending its ...

High-dose inactivated influenza vaccine is superior to the standard-dose vaccine in preventing hospitalisations for influenza ...

The MoU supports Saudi Vision 2030 and the National Transformation Program’s focus on localizing healthcare manufacturing ...

An announcement from Sanofi ( (SNY) ) is now available.